EMERGE HEALTH INTERNATIONAL INC
company.status.inactiveCIK 32567fmd_1BVDJYH1ZP00MAMNSWFZBNPZK4Manufacturing · Fabricated Structural Metal ProductsTemplate: Standard
Coverage: Jun 30, 2010 to Jun 30, 2019, 37 periods
Latest annual · FY2019
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (2)
- Net income
- (2)
- Free cash flow
- 0
Latest quarter · Q4 FY2019
Millions- Total revenues
- (2)
- Gross profit
- (1)
- Operating income
- (2)
- Net income
- (2)
- Free cash flow
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2016 to FY2019
- n/m
- Revenue, 5 yearsFY2014 to FY2019
- n/m
- Net income, 5 yearsFY2014 to FY2019
- n/m
EMERGE HEALTH INTERNATIONAL INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2019 | FY2018 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $1.9 million | -100% | 10-K 2021-09-30 · proof |
| Gross profit | $0 | $633,671 | -100% | 10-K 2021-09-30 · proof |
| Operating income | -$2.3 million | -$460,667 | 10-K 2021-09-30 · proof | |
| Net income | -$2.4 million | -$482,132 | 10-K 2021-09-30 · proof | |
| Cash from operating activities | -$49,290 | $25,134 | -296.1% | 10-K 2021-09-30 · proof |
| Total assets | $27,041 | $1.2 million | -97.7% | 10-K 2021-09-30 · proof |
| Total liabilities | $465,852 | $376,140 | +23.9% | 10-K 2021-09-30 · proof |
| Cash and cash equivalents | $17,291 | $0 | 10-K 2021-09-30 · proof |
- What was EMERGE HEALTH INTERNATIONAL INC's revenue in fiscal 2019?
- EMERGE HEALTH INTERNATIONAL INC reported revenue of $0 for fiscal 2019 (the year ended Jun 30, 2019), against $1.9 million the year before (-100%). Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What was EMERGE HEALTH INTERNATIONAL INC's gross profit in fiscal 2019?
- EMERGE HEALTH INTERNATIONAL INC reported gross profit of $0 for fiscal 2019 (the year ended Jun 30, 2019), against $633,671 the year before (-100%). Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What was EMERGE HEALTH INTERNATIONAL INC's operating income in fiscal 2019?
- EMERGE HEALTH INTERNATIONAL INC reported operating income of -$2.3 million for fiscal 2019 (the year ended Jun 30, 2019), against -$460,667 the year before. Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What was EMERGE HEALTH INTERNATIONAL INC's net income in fiscal 2019?
- EMERGE HEALTH INTERNATIONAL INC reported net income of -$2.4 million for fiscal 2019 (the year ended Jun 30, 2019), against -$482,132 the year before. Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What was EMERGE HEALTH INTERNATIONAL INC's cash from operating activities in fiscal 2019?
- EMERGE HEALTH INTERNATIONAL INC reported cash from operating activities of -$49,290 for fiscal 2019 (the year ended Jun 30, 2019), against $25,134 the year before (-296.1%). Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What are EMERGE HEALTH INTERNATIONAL INC's total assets?
- As of Jun 30, 2019, EMERGE HEALTH INTERNATIONAL INC reported total assets of $27,041, against $1.2 million a year earlier (-97.7%). Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What are EMERGE HEALTH INTERNATIONAL INC's total liabilities?
- As of Jun 30, 2019, EMERGE HEALTH INTERNATIONAL INC reported total liabilities of $465,852, against $376,140 a year earlier (+23.9%). Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
- What are EMERGE HEALTH INTERNATIONAL INC's cash and cash equivalents?
- As of Jun 30, 2019, EMERGE HEALTH INTERNATIONAL INC reported cash and cash equivalents of $17,291, against $0 a year earlier. Source: the 10-K filed with the SEC on Sep 30, 2021. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:32567&period_type=annual&limit=5"Information only, not investment advice.